This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Q3 2025 Management View Stephen D. Westhoven, President and CEO, indicated, "Fiscal 2025 continues to be an excellent year ...

Q2 2025 Management View Dave Cramer, President and CEO, reported sequential improvement in occupancy and contract rates, but ...

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

Dave Inc (NASDAQ:DAVE) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 revenue is ...

Advanced Micro Devices, Inc. sees strong Q2 revenue growth led by gaming, but margin compression impacts profits. Click for ...

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence ...

Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).

The company put up a bottom-line revenue that not only exceeded Wall Street expectations, but also its own history of ...

Core earnings per share was $1.27, reflecting a sequential increase from Q1 2025. Core Return on Tangible Common Equity-- Core return on tangible common equity was 18.03%, an increase from Q1 2025.

Nifty 50 EPS projected to grow by 10% in FY26, supported by fiscal measures and sectoral preferences, per Motilal Oswal.